in Newswire June 16, 2020

COVID-19 Test Maker Hit with Investor’s Class Action Over ‘100% Accurate’ Claim

by Erin Shaak

Last Updated on June 16, 2020

Gelt Trading, Ltd. v. Co-Diagnostics, Inc. et al.

Filed: June 15, 2020 § 2:20-cv-00368

A class action alleges Co-Diagnostics, Inc. caused investors to lose millions when the FDA contradicted the company’s “100% accuracy” claims for its COVID-19 tests.


Co-Diagnostics, Inc.



Last Updated on June 16, 2020 — 4:06 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.